Journals / KONURALP TIP DERGİSİ / 2023 / Cilt: 15 - Sayı: 1

Is the AURKB Gene Involved in Aml Cell Proliferation Since It is Targeted by miR-34a-5p and let-7b-5p?

AURKB Geni miR-34a-5p ve let-7b-5p Tarafından Hedeflendiğinden AML Hücre Proliferasyonunda Rol Oynar mı?

Pages
16–23
Publication Date
2023-03-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In conclusion, it was determined that miR-34a-5p and let-7b-5p could regulate AURKB expression in AML cells.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The production of normal blood cells in the bone marrow is interrupted in AML, which is characterized by the proliferation and accumulation of leukemic blasts.
📊
Key Findings & Data:When gene expression of Aurora kinases, which is reported to be highly expressed in AML, decreases, it may be possible to alleviate the clinical findings in AML.
💡
Conclusion & Impact:Conclusion: In conclusion, it was determined that miR-34a-5p and let-7b-5p could regulate AURKB expression in AML cells.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:AML · AURKB · miR-34a-5p

Abstract

Objective: The production of normal blood cells in the bone marrow is interrupted in AML, which is characterized by the proliferation and accumulation of leukemic blasts. Therefore, patients experience anemia and thrombocytopenia. When gene expression of Aurora kinases, which is reported to be highly expressed in AML, decreases, it may be possible to alleviate the clinical findings in AML. In this study, it was aimed to examine the relationship of AURKB with important miRNAs that have the potential to regulate gene expression. Method: HL60 and NB4 cells were transfected with important tumor suppressor miRNAs miR-34a-5p and let-7b-5p mimics. Then, its effects on proliferation were examined with WST-8 technique and its effects on AURKB gene expression were examined with qRT-PCR. Results: It was determined that these miRNAs negatively regulated proliferation in both AML cell lines and downregulated the expression level of the Aurora kinase B (AURKB) gene in the miRNA transfected group compared to the control group. Conclusion: In conclusion, it was determined that miR-34a-5p and let-7b-5p could regulate AURKB expression in AML cells. Therefore, it was thought that these miRNAs may have an important potential as a therapeutic biomarker in preventing excessive cell division and poor prognosis in AML.

Özet

Amaç: Lösemik blastların çoğalarak birikimiyle karakterize olan AML’de kemik iliğindeki normal kan hücrelerinin üretimi sekteye uğradığından hastalar anemi ve trombositopeni sorunu yaşamaktadır. AML'de yüksek oranda eksprese edildiği bildirilen Aurora kinazların gen ekspresyonu azaldığında AML'deki klinik bulguları hafifletmesi mümkün olabilir. Bu çalışmada, AURKB ile protein ekspresyonunu düzenleme potansiyeli bulunan önemli miRNA’ların ilişkisinin incelenmesi amaçlanmıştır. Metod: HL60 ve NB4 hücreleri, önemli tümor supresör miRNA’lardan olan miR-34a-5p ve let-7b-5p mimikleri ile tarnsfekte edilmiştir. Ardından WST-8 tekniğiyle proliferasyona etkileri incelenmiş ve qRT-PZR ile de AURKB gen ifadesine etkileri incelenmiştir. Bulgular: Her iki AML hücre hattında da bu miRNA’ların proliferasyonu negatif yönde regüle ettiği ve kontrol grubuna kıyasla miRNA transfekte edilen grupta Aurora kinase B (AURKB) geninin ifade seviyesini dowregüle ettikleri belirlenmiştir. Sonuç: Sonuç olarak miR-34a-5p ve let-7b-5p’nin AML hücrelerinde AURKB ifadesini düzenleyebileceği tespit edilmiştir. Bu nedenle, AML’deki aşırı hücre bölünmesi ve kötü prognozun engellenebilmesinde bu miRNA’ların terapötik bir biyomarker olarak önemli bir potansiyeli olabileceği düşünülmüştür.

🔖

Cite This Article

SUER, I., KAYA, M. (2023). Is the AURKB Gene Involved in Aml Cell Proliferation Since It is Targeted by miR-34a-5p and let-7b-5p?. KONURALP TIP DERGİSİ, Cilt: 15 - Sayı: 1, 16–23. https://ajindex.com/articles/886976

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Pelcovits A, Niroula R. Acute Myeloid Leukemia: A Review. R I Med J (2013). 2020;103(3):38-40
  2. De Kouchkovsky I, Abdul-Hay M. Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J. 2016;6
  3. Kojima K, Konopleva M, Tsao T, Nakakuma H, Andreeff M. Concomitant inhibition of Mdm2-p53 interaction and Aurora kinases activates the p53-dependent postmitotic checkpoints and synergistically induces p53-mediated mitochondrial apoptosis along with reduced endoreduplication in acute myelogenous leukemia. Blood. 2008;112(7):2886-95
  4. Carmena M, Earnshaw WC. The cellular geography of aurora kinases. Nat Rev Mol Cell Bio. 2003;4(11):842-54
  5. Chieffi P, Cozzolino L, Kisslinger A, Libertini S, Staibano S, Mansueto G, et al. Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation. Prostate. 2006;66(3):326-33
  6. García-Fernández E, De Diego JI, Collantes-Bellido E, Mendiola M, Prim MP, Pérez-Fernández E, et al. Aurora B kinase expression in laryngeal squamous cell carcinoma and its prognostic implications. Histopathology. 2011;58(3):368-76
  7. Yang J, Ikezoe T, Nishioka C, Tasaka T, Taniguchi A, Kuwayama Y, et al. AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo. Blood. 2007;110(6):2034-40
  8. Manfredi MG, Ecsedy JA, Meetze KA, Balani SK, Burenkova O, Chen W, et al. Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase. Proc Natl Acad Sci U S A. 2007;104(10):4106-11
  9. Emmrich S, Katsman-Kuipers JE, Henke K, Khatib ME, Jammal R, Engeland F, et al. miR-9 is a tumor suppressor in pediatric AML with t(8;21). Leukemia. 2014;28(5):1022-32
  10. Stavast CJ, van Zuijen I, Karkoulia E, Özçelik A, van Hoven-Beijen A, Leon LG, et al. The tumor suppressor MIR139 is silenced by POLR2M to promote AML oncogenesis. Leukemia. 2022;36(3):687-700
  11. Xue H, Hua LM, Guo M, Luo JM. SHIP1 is targeted by miR-155 in acute myeloid leukemia. Oncol Rep. 2014;32(5):2253-9. 12. 06.06.2022 [Available from: https://servers.binf.ku.dk/bloodspot/. 13. 07.06.2022 [Available from:
  12. Mardani R, Jafari Najaf Abadi MH, Motieian M, Taghizadeh-Boroujeni S, Bayat A, Farsinezhad A, et al. MicroRNA in leukemia: Tumor suppressors and oncogenes with prognostic potential. J Cell Physiol. 201